About (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one
(3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one (PubChem CID 93322023) has the molecular formula C16H18Cl2N2O2
and a molecular weight of 341.24 g/mol. Its IUPAC name is (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one.
Analyze (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one?
The IUPAC name of (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one (CID 93322023) is (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one.
What is the SMILES notation for (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one?
The canonical SMILES for (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one is C[C@@H]1C(=O)N(c2ccc(Cl)cc2Cl)CCN1C(=O)C1CCC1.
What is the InChIKey of (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one?
The InChIKey is BQAYPMZJHYNPSK-SNVBAGLBSA-N. The full InChI is InChI=1S/C16H18Cl2N2O2/c1-10-15(21)20(14-6-5-12(17)9-13(14)18)8-7-19(10)16(22)11-3-2-4-11/h5-6,9-11H,2-4,7-8H2,1H3/t10-/m1/s1.
What are the key properties of (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one?
(3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one has a molecular weight of 341.24 g/mol, XLogP of 3.36, 2 rotatable bonds, 0 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-4-(cyclobutanecarbonyl)-1-(2,4-dichlorophenyl)-3-methylpiperazin-2-one is sourced from PubChem (CID 93322023), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).